Cite
HARVARD Citation
Ferraresi, V. et al. (2022). Neoadjuvant immune checkpoint inhibitors in high-risk stage III melanoma. Human vaccines & immunotherapeutics. 18 (3), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ferraresi, V. et al. (2022). Neoadjuvant immune checkpoint inhibitors in high-risk stage III melanoma. Human vaccines & immunotherapeutics. 18 (3), p. . [Online].